You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Adalimumab and dexamethasone for treating non-infectious uveitis

  • Technology appraisal guidance
  • Reference number: TA460
  • Published:  26 July 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 Technologies
  • 3 Evidence
  • 4 Committee discussion
  • 5 Implementation
  • 6 Appraisal committee members and NICE project team

3 Evidence

The appraisal committee considered evidence submitted by AbbVie and Allergan and a review of these submissions by the assessment group. See the committee papers for full details of the evidence.


Next page 4 Committee discussion Previous page 2 Technologies
Back to top